J Biol Chem, Vol. 275, Issue 3, 1541-1550, January 21, 2000
Activation of DNA-dependent Protein Kinase by
Single-stranded DNA Ends*
Ola
Hammarsten
,
Lisa G.
DeFazio§, and
Gilbert
Chu¶
From the Departments of Medicine and Biochemistry, Stanford
University School of Medicine, Stanford, California 94305-5115
 |
ABSTRACT |
DNA-dependent protein kinase (DNA-PK)
is involved in joining DNA double-strand breaks induced by ionizing
radiation or V(D)J recombination. The kinase is activated by DNA ends
and composed of a DNA binding subunit, Ku, and a catalytic subunit,
DNA-PKCS. To define the DNA structure required for
kinase activation, we synthesized a series of DNA molecules and tested
their interactions with purified DNA-PKCS. The addition of
unpaired single strands to blunt DNA ends increased binding and
activation of the kinase. When single-stranded loops were added to the
DNA ends, binding was preserved, but kinase activation was severely
reduced. Obstruction of DNA ends by streptavidin reduced both binding
and activation of the kinase. Significantly, short single-stranded
oligonucleotides of 3-10 bases were capable of activating
DNA-PKCS. Taken together, these data indicate that kinase
activation involves a specific interaction with free single-stranded
DNA ends. The structure of DNA-PKCS contains an open
channel large enough for double-stranded DNA and an adjacent enclosed
cavity with the dimensions of single-stranded DNA. The data presented
here support a model in which duplex DNA binds to the open channel, and
a single-stranded DNA end is inserted into the enclosed cavity to
activate the kinase.
 |
INTRODUCTION |
Cells recognize and respond to a multitude of different DNA
lesions by activating pathways for apoptosis, cell cycle arrest, or DNA
repair. Little is known about how DNA lesions are recognized and
transduced into a signal for these cellular responses. In the case of
DNA double-strand breaks
(DSBs)1 induced by ionizing
radiation, recognition is critically important, because DSBs can lead
to chromosomal fragmentation and cell death, or to chromosomal
translocations and cancer.
Ionizing radiation activates the c-Abl tyrosine kinase, which has
undefined physiological functions (1, 2). Ionizing radiation also
activates the ATM kinase and DNA-dependent protein kinase
(DNA-PK), which have homologous kinase domains. ATM phosphorylates p53
to induce cell cycle arrest or apoptosis (3). DNA-PK is required for
the repair of DSBs produced by ionizing radiation and V(D)J
recombination, the process that generates immunological diversity in
antibodies and T cell receptors (4). Understanding how DNA-PK is
activated by DSBs can establish a paradigm for how proteins signal the
presence of DNA lesions.
DNA-PK is a serine-threonine protein kinase consisting of DNA binding
and catalytic subunits. The DNA binding subunit is the Ku protein, a
heterodimer of 70 and 86 kDa that binds to DNA ends, nicks, and
structures containing a transition fork between double-stranded DNA and
two single strands (5-9). The catalytic subunit of DNA-PK (DNA-PKCS) is a 465-kDa polypeptide (10) that is sufficient for the kinase activity of the enzyme (11-13). DNA-PKCS is
recruited for activation at DNA ends by Ku at physiological salt
concentrations (14, 15), but the kinase is fully activated by DNA ends
in the absence of Ku at low salt concentrations (12).
Several lines of evidence indicate that DNA-PK is involved in the
cellular response to DSBs. The otherwise latent kinase activity of
DNA-PK is activated by DNA ends (14, 16). The catalytic domain of
DNA-PKCS is mutated in the severe combined immunodeficiency mouse (17, 18), which is defective in the repair of DSBs (19-21). Additional studies have suggested that the catalytic kinase activity of
DNA-PK is required for rejoining DSBs both in intact cells (22) and in
a cell free system (23).
A number of DNA structures have been tested for their ability to
activate DNA-PK. DNA with blunt ends, 5' overhanging ends, or 3'
overhanging ends activate DNA-PK with equal efficiency (14), whereas
double-stranded DNA with hairpin ends fails to activate the kinase
(24). Supercoiled plasmid DNA fails to activate DNA-PK, but supercoiled
plasmid DNA containing the NRE1 sequence from mouse mammary tumor virus
was reported to activate the kinase (25, 26). Based on these studies,
it was not clear what specific DNA structure was critical for the
activation of DNA-PK.
In these earlier studies, the DNA structures were tested with different
enzyme preparations and a variety of protein substrates. Interpretations of the results were potentially confounded by several
factors: DNA preparations may have contained contaminating DNA
structures, and enzyme preparations often included Ku, which may have
altered or obscured properties of the DNA structures upon binding.
Therefore, to define precisely the DNA structure required for kinase
activation, we undertook a systematic study of a homogeneous
preparation of DNA-PKCS with a series of gel-purified DNA
structures in the absence of any cofactors or contaminating proteins.
 |
MATERIALS AND METHODS |
Oligonucleotides and Plasmids--
Oligonucleotides were
purified on oligonucleotide purification cartridges
(Poly-PakTM cartridge, Glen Research) to remove truncated
synthesis products. The oligonucleotides synthesized as oligo(dT) were
further purified on DNA-Pak HPLC columns (Dynal) using a
NaClO4 gradient in 25 mM Tris, pH 7.4, 5%
acetonitrile, desalted on Sep-Pak columns (Waters), lyophilized, and
dissolved in TE buffer (10 mM Tris-HCl, pH 7.4, 0.5 mM EDTA).
Double-stranded DNA fragments were made by annealing complementary
oligonucleotides in a 1:1 molar ratio in TE buffer and separated from
single-stranded DNA on 12% nondenaturing polyacrylamide gels, which
were then stained with ethidium bromide. Bands corresponding to
double-stranded DNA were cut out, and the DNA was electroeluted and
purified as described (27).
Sequences of all DNA fragments were derived from the 32-bp
double-stranded DNA fragment with the sequence
5'-GGCCGCACGCGTCCACCATGGGGTACAACTAC-3'. The DNA fragment f32-ss3'/5',
which contained unpaired single strands of 5 bases at both 3' and 5'
ends, was generated by annealing oligonucleotides containing the f32
sequences: oligo32-5T-1
(5'-[TTTTT]GGCCGCACGCGTCCACCATGGGGTACAACTAC[TTTTT]-3') and
oligo32-5T-2
(5'-[TTTTT]GTAGTTGTACCCCATGGTGGACGCGTGCGGCC[TTTTT]-3'). For
oligonucleotides described in this paper, unpaired nucleotides are in
brackets. The blunt-ended DNA fragment f42 was generated by annealing
oligo32-5T-1 to the fully complementary oligonucleotide oligo32-5A-2
(5'-AAAAAGTAGTTGTACCCCATGGTGGACGCGTGCGGCCAAAAA-3'). Shorter DNA
fragments were generated by successive shortening from the 3'-end of
the f32 sequence shown above.
Biotinylated oligonucleotides were synthesized using nucleotides
modified with biotin via a 12-carbon triethylene spacer (Glen Research). The oligonucleotides were then bound to recombinant streptavidin (13 binding units/mg, Roche Molecular Biochemicals) by
mixing in 10 µl of TE buffer at room temperature for 30 min. Dilution
of streptavidin-DNA complexes was done in TE buffer supplemented with
bovine serum albumin (0.2 mg/ml).
The plasmid pNRE1 was constructed by annealing the oligonucleotides
oligo37NRE1-1
(5'-[GATC]TAACTGAGAAAGAGAAAGACGACACATATGTTA-3') and
oligo37NRE1-2 (5'-[GATC]TAACATATGTGTCGTCTTTCTCTTTCTCAGTTA-3') and then cloning the annealed product into the BamHI
site in pBluescript II KS+ (Stratagene). For oligonucleotides described
in this paper, the NRE1 sequence is shown in boldface (25).
Plasmid DNA was prepared using the Wizard Plus Maxipreps DNA
Purification System (Promega) following the procedure provided by the
manufacturer. Supercoiled DNA was further purified by agarose gel
electrophoresis in the presence of ethidium bromide, electroelution, phenol/chloroform extraction, ethanol precipitation, and dialysis against TE buffer.
Relaxed plasmid was prepared by incubating supercoiled plasmid DNA with
topoisomerase I (4 units/µg plasmid DNA, Promega) in Buffer D (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM NaCl, 5% glycerol, 0.2 mg/ml bovine serum albumin) at
37 °C for 1 h. Absence of supercoiled plasmid was confirmed by
agarose gel electrophoresis in the absence of ethidium bromide.
Construction of DNA Fragments with Hairpin Ends or Ends with
Single-stranded Loops--
DNA fragments with hairpin ends were
constructed from self-annealing chemically phosphorylated
oligonucleotides containing sequences derived from the 32-bp DNA
fragment. The DNA fragment with hairpin ends, f44-H, was constructed as
shown in Fig. 2 by annealing two oligonucleotides, each containing
self-complementary sequences: oligo50-H-2
(5'-[ATGG]GGTACAACTACGATCTAGCTTCATGAAGCTAGATCGTAGTTGTACC-3') and oligo38-H-1
(5'-[CCAT]GGTGGACGCGTGCGGCCGGCCGCACGCGTCCACC-3'). For
oligonucleotides described in this paper, the underlined sequence anneals to complementary sequence located toward the 5' end.
Each oligonucleotide was allowed to self-anneal separately into a
structure with one single-stranded end and one hairpin end (see Fig.
2A), which was then purified from a nondenaturing 12% polyacrylamide gel. The two self-annealed oligonucleotides, which contained complementary single-stranded ends, were mixed together, ligated with T4-DNA ligase (Promega), resolved on a denaturing polyacrylamide gel (7 M urea, 40% formamide, 1× TBE
buffer run at 70 °C), and then stained with ethidium bromide. Under
these conditions, the fully ligated DNA fragment with hairpin ends
migrated more slowly than the partially ligated, nicked DNA fragment.
(Compare hairpin to nicked hairpin in Fig. 2B.)
Bands corresponding to the hairpin and the nicked hairpin were cut out
of the gels, electroeluted, and purified as described (27). To confirm
that the purified hairpin preparation was free of aberrant ligation
products and adopted a secondary structure of the correct length, the
hairpin preparation was analyzed on a 12% nondenaturing polyacrylamide
gel and stained with ethidium bromide (see Fig. 2C). As
expected, the putative hairpin-ended DNA fragment migrated with the
same mobility as open-ended DNA fragments of 44 bp. To further confirm
that the putative hairpin had the expected structure and was free of
nicks, the putative hairpin and nicked hairpin preparations were
cleaved with a panel of restriction enzymes. The cleavage products were
then labeled with [
-32P]ATP using the exchange
reaction for T4 polynucleotide kinase, resolved on a denaturing
polyacrylamide sequencing gel (7 M urea, 40% formamide,
1× TBE buffer run at 65 °C), and analyzed by autoradiography (see
Fig. 2D). The cleavage products migrated with the expected mobilities as outlined in Fig. 2A, confirming the structure
and purity of the hairpin preparation.
The DNA fragments ending in single-stranded DNA loops were generated
and purified by methods similar to those used for the DNA fragment with
hairpin ends. The f49NRE1-ssL5 fragment, which ends with 5 base
single-stranded DNA loops of dT and contains the NRE1 sequence from
mouse mammary tumor virus, was constructed from the two
oligonucleotides, oligo53-NRE1-1
(5'-[TTCTCA]GTTCGCGGCCATCGCCGCTCG[TTTTT]CGAGCGGCGATGGCCGCGAAC-3') and oligo55-NRE2
(5'-[TGAGAA]AGAGAAAGACGACATCCGCCTG[TTTTT]CAGGCGGATGTCGTCTTTCTCT-3'). A single self-annealing oligonucleotide was used to construct the
f32-ssL5 fragment, which ends with a 5-base single-stranded DNA loop
(oligo74:
5'-ATGGTGGACGCGGTACGCC[TTTTT]GGCGTACCGCGTCCACCATGGGGTAGTACTAC[TTTTT]GTAGTACTACCCC-3'). A single homologous self-annealing oligonucleotide was used to the
construct the f32-ssL10 fragment, which ends with a 10-base single-stranded DNA loop (oligo84:
5'-ATGGTGGACGCGGTACGCC[TTTTTTTTTT]GGCGTACCGCGTCCACCATGGGGTAGTACTAC[TTTTTTTTTT]GTAGTACTACCCC-3'). The annealed oligonucleotides were ligated, purified, and
analyzed as above, followed by a second round of purification on
denaturing polyacrylamide gels to remove truncated synthesis products
present in preparations of long oligonucleotides. Cleaved f49NRE1-ssL5 was prepared by incubating f49NRE1-ssL5 (400 nM) with 40 units BamHI (Promega) in 30 µl of kinase buffer at
37 °C for 4 h.
Purification of DNA-PKCS and
Ku--
DNA-PKCS and Ku were purified from placenta as
described (12). To omit multiple freeze-thaw cycles, which severely
degraded specific activity of the enzyme, DNA-PKCS and Ku
were kept in storage buffer (55% glycerol, 250 mM NaCl,
2.5 mM EDTA, 25 mM Tris-HCl, pH 7.4, 5 mM dithiothreitol, 10 mM 2-mercaptoethanol, 0.2 mg/ml bovine serum albumin, and a mixture of protease inhibitors) (12)
at
20 °C for short term storage. Under these conditions, a slow
decrease in kinase activity was detected, whereas no effect on the
ability of Ku to bind DNA could be detected even after several months.
For long term storage, DNA-PKCS and Ku were kept in Buffer
B (5% glycerol, 25 mM Tris-HCl, pH 7.4, 5 mM
EDTA, 250 mM NaCl, 10 mM 2-mercaptoethanol, and
a mixture of protease inhibitors) at
80 °C (12).
Kinase Assay--
Kinase activity was measured in 10 µl of
kinase buffer (10 mM Tris-HCl, pH 7.4, 1 mM
EDTA, 20 mM MgCl2, 2 mM
dithiothreitol, 10 mM 2-mercaptoethanol, 5% glycerol, 62.5 µM ATP) supplemented with 0.5 mg/ml substrate peptide and
[
-32P]ATP as described (27). Phosphate transfer to the
substrate peptide was calculated and expressed as mol of phosphate
transferred per mol of DNA-PKCS per min (mol
PO4/mol DNA-PKCS/min). Reaction times were
adjusted so that less than 10% of the substrate peptide and ATP was
consumed during the kinase reaction. All kinase assays were performed
at least twice. Although storage led to some loss of enzymatic
activity, there were no significant variations in relative kinase
activities for different DNA substrates when experiments were repeated.
Chan et al. (28) reported that DNA-PK autophosphorylation
was associated with inactivation under some conditions, but not when
peptide substrate was present, as was the case in our assays. To ensure
that our results were not compromised by this effect, we assessed the
potential effect of autophosphorylation under our experimental
conditions. Preincubation of DNA-PKCS with peptide and ATP
resulted in readily detectable autophosphorylation, but this
autophosphorylation did not have a detectable effect on subsequent activity of the kinase.
Electrophoretic Mobility Shift Assay (EMSA)--
EMSAs were
performed in kinase buffer with ATP and 0.5 mg/ml bovine serum albumin
as described (27), using 1 nM labeled f42 as the DNA probe
and 2.1 nM DNA-PKCS.
 |
RESULTS |
Unpaired Single-stranded DNA Ends Increase the Vmax for
DNA-PKCS Activation--
We previously reported that a
12-bp DNA fragment failed to activate the kinase significantly, but
when 5 bases of unpaired single strands were added to both ends of each
strand, the kinase was strongly activated (27). To explore the effect
of unpaired single-stranded ends in greater detail, we constructed a
series of symmetrical DNA fragments derived from the 12-bp DNA fragment (f12) by adding unpaired single strands at different ends (Fig. 1). To avoid the formation of secondary
structures, the single strands consisted of 5 bases of dT. The single
strands were added to f12 at its 3' ends (f12-ss3'), 5' ends
(f12-ss5'), or both 3' and 5' ends (f12-ss3'/5'). The 3' and 5' ends
contained hydroxyl groups to facilitate comparison. The DNA fragments
were tested for their ability to activate DNA-PKCS in low
salt kinase buffer. A wide range of DNA concentrations was used to
determine maximal enzyme activity (Vmax) for
each DNA fragment.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Unpaired single-stranded DNA ends increase
the Vmax for DNA-PKCS.
DNA-PKCS (1.9 nM) was incubated with different
DNA molecules in kinase buffer. The experiments included DNA fragments
with blunt ends (f12 and f22) or with
unpaired single strands at the 3' ends (f12-ss3'), 5' ends
(f12-ss5'), or both 3' and 5' ends (f12-ss3'/5').
Vmax was determined from the best fit to the
Michaelis-Menten equation. The Vmax values were
as follows (in mol PO4/mol DNA-PKCS/min):
f32-ss3'/5', 470; f12-ss3', 300; f22, 230; f12-ss5', 85; and
f12, too low to be determined.
|
|
Addition of unpaired single strands to the 5' ends of f12 (f12-ss5')
produced a moderate increase in Vmax. Addition
of unpaired 3' ends (f12-ss3') produced a larger increase in
Vmax, more than 3-fold greater than that for
unpaired 5' ends. In fact, the Vmax for f12-ss3'
was slightly but reproducibly higher than the
Vmax for f22, which is equivalent to the
highest Vmax for blunt-ended DNA of any length
(27). Addition of unpaired single strands at both 3' and 5' ends
(f12-ss3'/5') resulted in even more efficient activation, with a
Vmax more than 2-fold higher than the
Vmax for f22, as we reported previously
(27). Therefore, DNA-PKCS was activated most efficiently
when the DNA contained unpaired single strands. The kinase preferred 3'
ends over 5' ends but was activated most efficiently when both 3' and
5' ends were present.
Unpaired Single-stranded DNA Ends Increase DNA Binding to
DNA-PKCS--
The relative binding affinities of
different DNA substrates for DNA-PKCS can be estimated from
the steady-state kinetics of kinase activation as a function of DNA
concentration. At the low salt concentration of the kinase buffer used
in Fig. 1, the concentrations of f22, f12-ss3', and f12-ss3'/5'
that produced half maximal kinase activity
(Vmax/2) were equal to or lower than the enzyme
concentration (1.9 nM). This meant that most of the DNA was
bound to the enzyme, and the Km could not be
determined reliably.
Attempts to decrease the enzyme concentration resulted in an
unacceptable loss of kinase activity. On the other hand, the binding of
DNA to DNA-PKCS is destabilized by salt (12). Therefore, to
obtain a better estimate of both Km and
Vmax for each DNA substrate in a single buffer
system, we supplemented the kinase buffer with 25 mM NaCl
(Table I). Although this buffer system required significantly higher DNA concentrations to reach
Vmax, we were able to generate data to fit the
Michaelis-Menten equation. The Vmax for each DNA
substrate was slightly lower than that found for the low salt buffer,
but their relative values were preserved (compare Table I and Fig.
1).
View this table:
[in this window]
[in a new window]
|
Table I
Kinetics of DNA-PKCS activation for different DNA substrates
DNA-PKCS (1.9 nM) was activated by different DNA
substrates (defined in Fig. 1) for a range of DNA concentrations in
kinase buffer supplemented with 25 mM NaCl.
Km (in mM) and Vmax
(in mol PO4/mol DNA-PKCS/min) were determined by best
fit of the data to the Michaelis-Menten equation, V = (Vmax [S])/(Km + [S]), where [S] is the DNA
concentration. The R value is a measure of the
quality of the fit, with R = 1 representing a perfect
fit. The Km and Vmax for f12 were
not determinable (ND) because kinase activation was too weak to permit
reliable measurements. The Km values for f12-ss5'
and f12-ss3' were not different to any significant degree, because the
R values remained essentially unchanged when the
Km values were both set to 48 or to 32 nM. The apparent Km for f12-ss3'/5' was
not significantly greater than the concentration of DNA-PKCS,
so we could only estimate an upper limit for the actual
Km.
|
|
Assuming that binding of DNA to enzyme was rate-limiting for kinase
activity, Km reflected the apparent dissociation constant Kd between DNA and DNA-PKCS.
The Km for unpaired 3' ends (f12-ss3') was
approximately equal to that for unpaired 5' ends (f12-ss5'), despite a
nearly 3-fold greater Vmax. Thus, the enzyme
showed no clear preference for binding to unpaired 3' ends over
unpaired 5' ends, although it showed a significant increase in
activation by 3' ends once binding was complete. Strikingly, the
Km for DNA fragments with unpaired single strands at
both 3' and 5' ends (f12-ss3'/5'), was less than
the
Km for f12-ss3' or f12-ss5' and less than
than the Km for a blunt-ended duplex DNA containing
the same total number of bases, f22. Furthermore, the
Vmax for f12-ss3'/5' was more than 2-fold greater than for f12-ss3' and f22 and more than 6-fold higher than for f12-ss5'. These results suggest that the enzyme binds productively to DNA in a conformation that utilizes both 3' and 5'
single-stranded ends.
Single-stranded Loops or Hairpins at DNA Ends Severely Reduce
DNA-PKCS Activation--
Because unpaired single-stranded
DNA ends increased kinase activation, we wondered whether the increase
was due to unpaired DNA or to single-stranded DNA ends. DNA fragments
were constructed with ends consisting of a covalent DNA hairpin or a
single-stranded DNA loop. Construction of these molecules utilized
oligonucleotides that contained self-complementary sequences. Annealing
occurred by both intramolecular and intermolecular reactions, and the
ligation products were a complex mixture of different molecules
produced by different annealing reactions and different degrees of
ligation. Thus, special care was required to purify the DNA fragments
with hairpin ends and single-stranded DNA loops (see under "Materials and Methods") and to verify that the purified preparation was free of
contaminating DNA molecules (Fig.
2).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Construction of DNA fragment with hairpin
ends. A, schematic of the construction of the
hairpin-ended DNA fragment f44-H. Two self-annealing oligonucleotides,
separately purified on nondenaturing polyacrylamide gels, were ligated
with T4-DNA ligase. Ligation products included the fully ligated
hairpin-ended DNA fragment (hairpin) and partially ligated
products containing a nick (nicked hairpin). The positions
of the nicks are indicated by asterisks. Shown are expected
lengths of the single-stranded DNA fragments generated by cleavage with
the restriction endonucleases AflIII, BstUI, and
StyI. Cleavage sites for the restriction enzymes are
indicated by arrows. B, preparative separation of
the ligated oligonucleotides by denaturing gel electrophoresis. The
ligated oligonucleotide products were resolved by electrophoresis and
stained with ethidium bromide (lane 1). Positions of hairpin
and nicked hairpin are shown. To mark the position of the nicked
hairpin, an 88-base oligonucleotide was used as a size marker
(lane 2). C, analysis of the hairpin-ended DNA
fragment by nondenaturing gel electrophoresis. The hairpin-ended DNA
fragment was electroeluted from the gel in B and analyzed by
nondenaturing gel electrophoresis. The hairpin (lane 1)
migrated with the expected mobility of an open-ended 44-bp DNA
fragment, as determined by molecular weight markers (lanes 2 and 3). D, analysis of the hairpin-ended DNA
fragment by denaturing gel electrophoresis. The hairpin and nicked
hairpin were electroeluted from the gel in B and cleaved with
AflIII, BstUI, and StyI. The cleavage
products were labeled with T4 polynucleotide kinase, resolved by
denaturing gel electrophoresis, exposed to autoradiography, and
compared with the expected fragment lengths shown in
A.
|
|
Three molecules with covalently closed DNA ends were constructed: a
44-bp hairpin-ended DNA fragment (f44-H), a 32-bp DNA fragment with a
single-stranded loop of 5 bases of dT at each end (f32-ssL5), and a
32-bp DNA fragment with a single-stranded loop of 10 bases of dT at
each end (f32-ssL10). For comparison, two molecules with open DNA ends
were also constructed: a 32-bp DNA fragment with blunt ends (f32) and a
32-bp DNA fragment with 5 bases of single-stranded DNA at each of the
3' and 5' ends (f32-ss3'/5'). The molecules were designed to be
approximately matched in overall length (Fig. 3).
The DNA molecules with hairpin ends and single-stranded loops activated
DNA-PKCS only slightly over background. This small degree
of activation was reproducible and not due to a small amount of
contaminating open-ended DNA, because activation reached
Vmax at relatively low DNA concentrations. The
inefficiency of activation was not due to the presence of contaminating
inhibitors, because restriction enzyme cleavage of the molecules
resulted in robust activation of the kinase (data not shown).
Furthermore, activation by DNA with single-stranded loops was
inefficient for NaCl concentrations from 0 to 100 mM and
Mg2+ and Mn2+ concentrations from 5 to 20 nM (data not shown).
Contrary to our results, Morozov et al. (29) previously
reported that DNA with single-stranded loops efficiently activated DNA-PK. However, no protocol for purification of the DNA substrate was
described. In fact, purification of DNA substrate was of vital importance, because we found that aberrant products were formed with
high efficiency when self-complementary oligonucleotides were annealed
and ligated. Indeed, DNA-PKCS was activated by partially purified f32-ssL10 preparations.
Significantly, f32-ss3'/5' was 30-fold more potent than f32-ssL10 in
activating DNA-PKCS, even though the two molecules are identical except for the presence or absence of single-stranded ends.
These results demonstrate that DNA molecules containing hairpin ends or
ends with single-stranded loops fail to activate the kinase
efficiently. In fact, they suggest that full kinase activation requires
interaction with free single-stranded DNA ends.
DNA Ends with Single-stranded Loops Bind Efficiently to
DNA-PKCS--
Because the addition of hairpins or
single-stranded loops to DNA ends severely reduced kinase activation,
we wished to determine whether this reduction was due to loss of
binding to the enzyme. The DNA fragments in Fig.
3 were compared for their ability to compete for binding to a labeled blunt-ended DNA fragment (f42) in an
EMSA (12). In this assay, labeled f42 and unlabeled competitor DNA were
mixed together and then incubated with DNA-PKCS in kinase buffer. The resulting protein-DNA complexes were resolved by
nondenaturing polyacrylamide gel electrophoresis and analyzed by
autoradiography and phosphorimaging. The concentration of competitor
DNA causing 50% inhibition of binding to f42 (IC50) was
calculated by fitting the phosphorimager data to simple competitive
inhibition kinetics. Comparison of the IC50 for different
competitor DNAs was used as a measurement of relative binding
affinities.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
DNA ends consisting of single-stranded loops
or hairpins fail to efficiently activate DNA-PKCS.
DNA-PKCS (1.9 nM) was incubated with different
DNA molecules in kinase buffer. The experiments included three
molecules with covalently closed DNA ends: a 44-bp hairpin-ended DNA
fragment (f44-H), a 32-bp DNA fragment with a
single-stranded loop of 5 bases at each end (f32-ssL5), and
a 32-bp DNA fragment with a single-stranded loop of 10 bases at each
end (f32-ssL10). For comparison, the experiments also
included two homologous molecules with open DNA ends: a 32-bp DNA
fragment with blunt ends (f32) and a 32-bp DNA fragment with
5 bases of single-stranded DNA at the 3' and 5' ends
(f32-ss3'/5'). Vmax was determined
from the best fit to the Michaelis-Menten equation. The
Vmax values were as follows (in mol
PO4/mol DNA-PKCS/min): f32-ss3'/5', 230; f32,
110; f32-ssL5, 13; f32-ssL10, 8; and f44-H, 8.
|
|
The EMSA was used to measure binding of DNA-PKCS (Fig.
4) to the DNA fragments in Fig. 3 and to
plasmid DNA. The DNA fragment with unpaired single-stranded DNA at 3'
and 5' ends (f32-ss3'/5') was the most active competitor
(IC50 = 7 ng/ml), more than 4-fold more potent than
blunt-ended DNA, f42 (IC50 = 30 ng/ml). This confirms the
conclusion from Table I that the presence of unpaired single strands
stimulates binding of DNA to DNA-PKCS. Although DNA with
ends consisting of single-stranded loops (f32-ssL10) was unable to
activate DNA-PKCS, it competed for binding to
DNA-PKCS (IC50 = 20 ng/ml) slightly more
effectively than f42. Hairpin-ended DNA (f44-H) competed for binding to
DNA-PKCS (IC50 = 300 ng/ml) about 10-fold less
effectively than f42. Nevertheless, the competition by f44-H was
significant when compared with competition by relaxed plasmid DNA (data
not shown) or supercoiled plasmid DNA (IC50 = 12,800 ng/ml). This was consistent with our previous report that hairpin-ended
DNA binds but fails to efficiently activate the DNA-PK holoenzyme.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 4.
DNA ends with single-stranded loops bind
efficiently to DNA-PKCS. A labeled 42-bp blunt-ended
DNA fragment (f42) (1 nM, 30 ng/ml) was mixed with
competitor DNA in 2-fold increments of concentration and then incubated
with DNA-PKCS (2.1 nM) in kinase buffer. The
resulting protein-DNA complexes were resolved by nondenaturing gel
electrophoresis and visualized by autoradiography (top
panel). Complex formation was displayed graphically (bottom
panel) after quantification by phosphorimager of the radioactivity
in the protein-DNA complexes (migrating at the position marked
DNA-PKCS and retained in the well of the gel). The free
(unbound) DNA migrated at the position marked F.
|
|
We conclude that DNA-PKCS binds effectively to DNA ending
in single-stranded loops, despite failing to activate the kinase. The
transition fork in f32-ssL10 from double-stranded DNA to two single
strands appears to be a critical determinant for effective binding to
the enzyme, because hairpin-ended DNA, which lacks such a transition
fork, was
as effective as a competitor for binding. Thus,
DNA-PKCS binds effectively to DNA containing a transition
fork from double-stranded DNA to two single strands but is activated
only if the ends of single-stranded DNA are present.
Blocking DNA Ends with Streptavidin Interferes with Binding and
Activation of DNA-PKCS--
Our experiments suggested
that in order to be activated efficiently, DNA-PKCS must
interact with the ends of single-stranded DNA. Modification of the ends
to include 5'-phosphates had no effect on kinase activation (data not
shown). To further investigate the structural requirements of the
single-stranded ends, we constructed a DNA fragment with all four ends
modified with biotin on the terminal nucleotide (f32-ss3'B/5'B) (Fig.
5A). Biotin modification by
itself had no effect on the ability of the DNA to activate the kinase
in the absence of streptavidin.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Blocking DNA ends with streptavidin
interferes with activation of DNA-PKCS. A,
streptavidin interferes with kinase activation when bound to the
activating DNA. Saturating concentrations (20 nM) of DNA
fragment modified with biotin at the 3' and 5' terminal nucleotides
(f32-ss3'B/5'B) or a matching unmodified DNA fragment
(f32-ss3'/5') were mixed with increasing concentrations of
streptavidin and then incubated with DNA-PKCS (1.9 nM) in kinase buffer. As a control to prevent streptavidin
binding to DNA, the biotinylated DNA was mixed with excess free biotin
(300 nM) before mixing with streptavidin
(f32-ss3'B/5'B + free biotin). B, streptavidin
interferes with kinase activation less efficiently when bound to
internal DNA sites. DNA fragments (1.25 nM) modified with
biotin at various locations were mixed (+) or not mixed ( ) with 250 ng of streptavidin (Str) and then incubated with
DNA-PKCS in kinase buffer to measure kinase activation. The
DNA fragment f32-ss3'/5' was modified at the 3' and 5' terminal
nucleotides (f32-ss3'B/5'B), at the four internal positions
adjacent the unpaired single strands (f32B-ss3'/5'), at the
3' terminal nucleotides (f32-ss3'B/5'), and at the 5'
terminal nucleotides (f32-ss3'/5'B).
|
|
The biotinylated DNA f32-ss3'B/5'B was then mixed with increasing
concentrations of streptavidin and tested for kinase activation. Streptavidin consists of a tetramer of four identical 15-kDa subunits, and it binds tightly to biotin. Addition of streptavidin produced an
80% inhibition of kinase activity. This inhibition was due to a
decrease in Vmax for the kinase, because the DNA
was present in supersaturating concentration (20 nM).
Inhibition required streptavidin bound to DNA, because no inhibition
was observed when streptavidin was added to DNA lacking biotin
(f32-ss3'/5') or when streptavidin binding to the biotinylated DNA was
blocked by excess free biotin.
We further explored the effect of streptavidin binding to DNA by
constructing a series of DNA fragments with biotinylated nucleotides at
different positions (Fig. 5B). In these experiments, the DNA
concentration was decreased to 1.25 nM, a nearly saturating concentration for f32-ss3'/5'. Under these conditions, activation of
the kinase by DNA with biotin at all four ends (f32-ss3'B/5'B) was
inhibited 95% by adding streptavidin. This nearly complete inhibition
allowed us to explore the more subtle effects produced by placing
biotin at other positions.
When biotin was added to the DNA fragment at the four internal
positions adjacent to the unpaired single strands (f32B-ss3'/5'), kinase inhibition still occurred with the addition of streptavidin, but
the effect was significantly less pronounced. When the biotin was
placed on only the 3' ends (f32-ss3'B/5') or only on the 5' ends
(f32-ss3'/5'B), inhibition by streptavidin was even weaker. Interestingly, obstruction of the 3' end produced a consistently larger
effect than obstruction of the 5' end. This was consistent with our
finding that DNA-PKCS was activated more efficiently by its
interaction with 3' ends (Fig. 1).
To determine whether blocking DNA ends with streptavidin had an effect
on binding to DNA-PKCS, we tested the DNA for its ability to compete with unmodified DNA for binding to DNA-PKCS in
an EMSA. Unlabeled biotinylated DNA (f32-ss3'B/5'B) was tested for its ability to compete with labeled unmodified DNA (f42) for binding to
DNA-PKCS (Fig.
6A). In the absence of
streptavidin, the biotinylated DNA competed effectively for binding, as
expected. Upon addition of streptavidin, competition by the
biotinylated DNA was
as effective.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Blocking DNA ends with streptavidin
interferes with binding to DNA-PKCS. A, DNA
ends blocked by streptavidin fail to compete for DNA-PKCS
binding. DNA modified with biotin at 3' and 5' terminal nucleotides
(f32-ss3'B/5'B) was mixed (+ Str) or not mixed
( Str) with streptavidin and then mixed with labeled
unmodified 42-bp blunt-ended DNA f42 (1 nM), followed by
incubation with DNA-PKCS (2.1 nM) in kinase
buffer. The resulting protein-DNA complexes were resolved by
nondenaturing polyacrylamide gel electrophoresis and visualized by
autoradiography (top panel). Complex formation was displayed
graphically (bottom panel) as described in Fig. 4.
B, streptavidin interference of binding to
DNA-PKCS is reflected in the Km for
kinase activation. The DNA used in Fig. 6A was incubated
over a range of concentrations with DNA-PKCS (1.1 nM) in kinase buffer to assess kinase activation. The
Vmax and Km were determined
from the best fit to the Michaelis-Menten equation. For f32-ss3'B/5'B Str, Vmax = 250 mol PO4/mol
DNA-PKCS/min and Km = 0.5 nM. This Km is only an upper limit
because it was greater than the DNA-PKCS concentration. For
f32-ss3'B/5'B+Str, Vmax = 95.5 mol
PO4/mol DNA-PKCS/min and Km = 5.4 nM.
|
|
To further examine the effect of blocking DNA with streptavidin, we
tested the biotinylated DNA (f32-ss3'B/5'B) for its ability to activate
DNA-PKCS over a range of DNA concentrations (Fig. 6B). The data were fit to the Michaelis-Menten equation to
provide estimates of Km and
Vmax. Addition of streptavidin produced a nearly
3-fold decrease in Vmax, consistent with the
result in Fig. 5A, and a greater than 10-fold increase in
the Km, consistent with the EMSA result in Fig.
6A. Thus, blocking DNA ends with streptavidin inhibited both
binding and maximal activation of the kinase, suggesting that the free
ends of single-stranded DNA are involved in a specific interaction with
DNA-PKCS .
Short Single-stranded DNA Activates
DNA-PKCS--
Because single-stranded DNA ends were
necessary for the activation of DNA-PKCS, we wondered
whether single-stranded DNA is capable of activating
DNA-PKCS in the absence of double-stranded DNA. To explore
this possibility, we tested the activation of DNA-PKCS by
single-stranded oligonucleotides synthesized as homo-oligomers, oligo(dT). At a sufficiently high concentration (25 µM),
oligo(dT) activated DNA-PKCS efficiently when the DNA
length was between 3 and 10 bases (Fig.
7A). No activation was
detectable for the mononucleotide dT1 or for oligo(dT) lengths of 20 bases or greater.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Short single-stranded oligonucleotides
activate DNA-PKCS. A, DNA-PKCS
activation by single-stranded oligonucleotides as a function of length.
DNA-PKCS (1.9 nM) was incubated with
single-stranded oligo(dT) of different lengths (25 µM) in
kinase buffer to assess kinase activation. B, comparison of
DNA-PKCS activation by double-stranded DNA and dT5.
DNA-PKCS (1.9 nM) was incubated with 32-bp
blunt-ended DNA (f32) or single-stranded dT5 in kinase buffer, and
kinase activity was determined. As a control, dT5 (25 µM)
was digested to mononucleotides by S1-nuclease (dT5/S1) and
then incubated with DNA-PKCS. Kinase activation was also
determined for an equimolar (25 µM) mixture of dT5 and
dT30 (dT5 + dT30). Vmax and apparent
Km were determined by the best fit to the
Michaelis-Menten equation. For f32, Vmax = 230 mol PO4/mol DNA-PKCS/min and
Km = 1.5 nM. For dT5,
Vmax = 79 mol PO4/mol
DNA-PKCS/min and Km = 7200 nM.
|
|
We next compared single-stranded oligonucleotide (dT5) and
double-stranded DNA (f32) for their ability to activate
DNA-PKCS as a function of DNA concentration. Special
precautions were taken to remove organic impurities that inhibited the
kinase (see under "Materials and Methods"). Presence of these
impurities was evident by a decline in kinase activity as the
concentration of less purified dT5 preparations increased. Successful
removal of the impurities was supported by absence of a decline in
kinase activity as the concentration of the fully purified dT5
preparation increased from 10,000 to 50,000 nM (Fig.
7B).
The Vmax for dT5 was 30% of that obtained with
the 32-bp blunt-ended DNA fragment f32. Kinase activity reached
half-maximal levels at a DNA concentration of 7200 nM for
dT5 and 1.5 nM for f32. Thus, dT5 bound to
DNA-PKCS with an affinity at least 3 orders of magnitude
lower than that for double-stranded f32. Activation by dT5 was not due
to contamination of the preparation with double-stranded DNA, because
activation was abolished by digestion of dT5 to mononucleotides with
the single-strand specific nuclease S1. When NaCl was added to the
kinase buffer at concentrations of 50 and 100 mM,
activation by dT5 became completely undetectable, even though
activation by f32 was only partially suppressed (data not shown). Thus,
activation of DNA-PKCS by dT5 was more salt-sensitive than
activation by f32, consistent with a weaker interaction between
DNA-PKCS and dT5. Nevertheless, once dT5 was bound to the
enzyme, it was capable of activating DNA-PKCS to
significant levels.
We previously reported that activation of DNA-PKCS by
double-stranded DNA was inhibited by the single-stranded DNA dT30 (27). We found that the activation of DNA-PKCS by dT5 was
similarly inhibited by dT30 (Fig. 7B). This lends further
support to the idea that DNA-PKCS is activated by a
specific interaction with short single-stranded DNA.
The NRE1 DNA Sequence Is Not Sufficient to Fully Activate
DNA-PKCS--
Giffen et al. (25, 26) have
reported that the NRE1 (negative regulatory element 1) sequence from
the mouse mammary tumor virus long terminal repeat binds Ku and
activates DNA-PK in the absence of DNA ends. This observation raises
the possibility that a specific DNA sequence might be an exception to
our conclusion that single-stranded DNA ends are necessary for
efficient activation of DNA-PKCS.
To examine whether the NRE1 sequence activates DNA-PKCS
under our experimental conditions, we constructed a DNA fragment
containing the NRE1 sequence and terminating in single-stranded DNA
loops (f49NRE1-ssL5). Compared with DNA with blunt ends (f42), the
f49NRE1-ssL5 DNA failed to efficiently activate DNA-PKCS in
either the absence or the presence of Ku (Fig.
8A). In fact, addition of the
NRE1 sequence provided no increase over the limited activation observed with the homologous DNA fragment lacking the sequence (f32-ssL5). Failure to activate the kinase was not due to the presence of inhibitors in the f49NRE1-ssL5 DNA preparation, because efficient activation was observed when the DNA was cleaved with
BamHI.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 8.
The NRE1 sequence is not sufficient for
efficient kinase activation. DNA-PKCS (1.9 nM) with (+) or without ( ) Ku (7.5 nM) was
incubated with different DNA molecules (10 nM) and assayed
for kinase activity. A, the NRE1 sequence in a DNA fragment
ending in single-stranded loops fails to activate the kinase. The DNA
fragment f49NRE1-ssL5 contains the NRE1 sequence and ends consisting of
single-stranded DNA loops of 5 bases of dT. As a control, this fragment
was cleaved with BamHI (f49NRE1-ssL5/BamHI). The
other DNA fragments are defined in Fig. 3. B, The NRE1
sequence in a supercoiled plasmid fails to activate the kinase. The
NRE1 sequence was cloned into pBluescript (pNRE1), which was tested for
activation of DNA-PKCS. As controls, kinase activation was
measured for the parental plasmid without the NRE1 sequence
(pBluescript), pNRE1 plasmid cleaved with BamHI
(pNRE1/BamHI), and a 42-bp blunt-ended DNA fragment (f42).
The plasmid DNAs were added to a concentration of 17 nM
(0.03 mg/ml), and f42 was added to 10 nM.
|
|
Because Giffen et al. (25, 26) tested the NRE1 sequence in
the context of plasmid DNA, we cloned the NRE1 sequence into the
pBluescript plasmid. The resulting plasmid (pNRE1) also failed to
activate DNA-PKCS (Fig. 8B). Failure to activate
was not due to inhibitors in the pNRE1 DNA preparation: pNRE1 cleaved
with BamHI was as efficient as f42 in activating
DNA-PKCS when Ku was present. In the absence of Ku, pNRE1
cleaved with BamHI failed to activate DNA-PKCS
efficiently, because effective recruitment of DNA-PKCS to
the end of a long DNA fragment requires Ku (12). Thus, the NRE1
sequence failed to activate DNA-PKCS under the experimental
conditions used in this study.
 |
DISCUSSION |
Binding of DNA-PKCS to DNA Ends Occurs at a Transition
Fork between Double-stranded DNA and Two Single Strands--
To define
the structure in DSBs that activates DNA-PKCS, we
synthesized a series of DNA fragments with different end structures. The binding of DNA-PKCS to different DNA ends was measured
by either of two methods: enzyme kinetics to determine an effective dissociation constant Kd and competitive EMSAs to
assess relative binding affinity. When unpaired single strands were
added to a 12-bp DNA fragment at the 3' end (f12-ss3') or at the 5' end
(f12-ss5'), the polarity of the unpaired single strand did not have a
significant effect on the dissociation constant Kd. On the other hand, for a DNA fragment containing both 3' and 5' unpaired ends (f12-ss3'/5'), the Kd was less than
the Kd for f12-ss3' or f12-ss5' and less
than
the Kd for f22, a blunt-ended
DNA fragment with the same total number of bases as f12-ss3'/5'. These
data suggest that binding of DNA to DNA-PKCS involves
melting of the end to form a transition fork between double-stranded
DNA and two single strands. Thus, when the transition fork was
preformed, part of the binding energy was not utilized to melt the DNA
end, and binding increased.
In further support of this hypothesis, a competitive EMSA showed that
DNA with unpaired ends (f32-ss3'/5') bound to DNA-PKCS much
more effectively than DNA with blunt ends. DNA with ends consisting of
single-stranded loops (f32-ssL10) bound effectively to
DNA-PKCS, consistent with the idea that the single-stranded loop provided a preformed transition fork between double- and single-stranded DNA. By contrast, when the DNA ends were covalently sealed by a hairpin to stabilize the ends against melting, the resulting hairpin-ended DNA (f44-H) bound to DNA-PKCS much
less effectively.
Efficient Activation of DNA-PKCS by DNA Ends Requires
Free Single-stranded Ends--
The DNA structures conferring optimal
kinase activation were somewhat different from those conferring optimal
binding to the enzyme. First, end polarity was important for kinase
activation: unpaired 3' ends were more potent than unpaired 5' ends in
activating the kinase. Second, single-stranded DNA in the absence of
free ends was not sufficient for kinase activation because single
strand loops (f32-ssL5 and f32-ssL10) failed to activate the kinase, despite strong binding of f32-ssL10 to DNA-PKCS. To further
explore the importance of free DNA ends, we synthesized DNA fragments in which the ends were obstructed by streptavidin. When streptavidin obstructed the single-stranded ends of the DNA fragment
(f32-ss3'B/5'B), both kinase activation and binding to
DNA-PKCS were strongly inhibited.
The foregoing experiments demonstrated that DNA must contain free
single-stranded ends to efficiently activate the kinase. We then tested
whether free single strands alone were sufficient for kinase
activation. Short single-stranded oligonucleotides were able to
significantly activate DNA-PKCS. Nevertheless, activation by the oligonucleotides required very high concentrations of DNA, and
maximal activation was 30% that of double-stranded DNA. A possible
explanation is that full activation of the kinase requires interactions
with both double and single-stranded DNA. Alternatively, activation may
occur solely through an interaction with single-stranded DNA, but full
activation requires correct presentation of the single-strand in the
context of a double-stranded DNA end.
Structural Model for How DNA Ends Activate
DNA-PKCS--
Single molecule cryo-electron microscopy
suggests the presence of an enclosed cavity within the
DNA-PKCS molecule (30). Electron microscopy of
two-dimensional DNA-PKCS crystals reveals three openings to
the cavity, each with the dimensions of single-stranded DNA (27). One
opening is adjacent to an open channel large enough to accommodate
double-stranded DNA. We have hypothesized that DNA-PKCS
interacts with DNA ends via both the open channel and the enclosed
cavity (Fig. 9A). Indeed,
biochemical data show that DNA-PKCS contains separate but
interacting binding sites for double and single-stranded DNA (27).

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 9.
Model for interactions between DNA and
DNA-PKCS. A, structure of
DNA-PKCS from electron crystallography with superimposed
schematic of a bound DNA end. Double-stranded DNA binds to the open
channel in DNA-PKCS. The binding energy is utilized in part
to melt the DNA end and facilitate insertion of an unpaired single
strand into an enclosed cavity adjacent to one end of the open channel.
Cooperative interaction between the double and single-stranded DNA
binding sites confers strong binding to DNA ends. When the enclosed
channel is occupied by the single-stranded DNA end, the kinase is
activated. B, role of DNA-PKCS in DNA repair. A
cross-sectional view of DNA-PKCS is shown in the context of
interactions between the enzyme and DNA ends. In the model, the
synapsis of two DNA ends is mediated by interactions with Ku molecules
bound to each end (not shown) and two associated DNA-PKCS
molecules as shown. The kinase is activated (kinase on) when an
unpaired single strand is threaded into one of two openings of the
enclosed cavity. The kinase is inactivated (kinase off) when threading
of the ends reaches a critical length, thus allowing single strands
from opposing ends to anneal to each other in a region of
microhomology.
|
|
The results in this paper support and refine this hypothesis. When
unpaired single-stranded ends were added to double-stranded DNA,
binding was enhanced by facilitating interactions with both double and
single-stranded binding sites. Binding was weak for single-stranded dT5
in the absence of double-stranded DNA, although kinase activation was
significant for sufficiently high dT5 concentrations. It should be
noted that binding was strong for DNA containing single-stranded loops.
This raises the possibility that the cavity can be deformed to permit
passage of a single-stranded loop. Alternatively, part of the
single-stranded DNA binding site may lie outside the enclosed cavity.
Once DNA is bound to DNA-PKCS, we propose a model in which
the kinase is activated when single-stranded DNA is threaded into the
enclosed cavity (Fig. 9A). This model is consistent with
several findings. Unpaired single-stranded ends on DNA enhance kinase activation, because they are more easily threaded into the enclosed cavity. Single-stranded loops, hairpin ends, and ends blocked by
streptavidin fail to efficiently activate the kinase because they are
not easily threaded into the cavity. For example, the streptavidin
tetramer is 45 × 55 Å (31), and duplex DNA is 24 Å in diameter,
whereas the cavity openings are 8 × 16 Å.
Fig. 9B shows the model for DNA-PKCS interacting
with DNA in the context of DSB repair. Upon recruitment of
DNA-PKCS to the DNA ends by Ku, the model shows DNA bound
to the open channel. The ends are then brought into synapsis by a
mechanism, mediated in part by Ku (32) and perhaps by
DNA-PKCS (33). Once synapsis occurs, the model proposes
that DNA-PKCS is activated when a single-stranded end is
inserted into the enclosed cavity. One single-stranded end may be
threaded into the opening to the cavity adjacent to the open channel.
The other single-stranded end may be threaded into an opening on the
opposing DNA-PKCS molecule, further stabilizing synapsis of
the two DNA ends. A contribution from both single-stranded ends is
consistent with the 2-fold increase in Vmax for
the kinase when unpaired 5' ends are added to a DNA molecule with
unpaired 3' ends (Fig. 1).
Nicked DNA fails to activate DNA-PKCS efficiently (24),
even though a DNA nick contains two single-stranded ends that
potentially activate the kinase. Perhaps the kinase is not activated
because the two single-stranded ends at a DNA nick are topologically
different from the single-stranded ends at a DSB. It is also possible
that DNA-PKCS activation may require synapsis of a second
DNA-PKCS molecule (34), and the synaptic configuration
depicted in Fig. 9B cannot form at a DNA nick.
Deletions in the coding joints from V(D)J recombination suggest that
end-processing is capable of generating unpaired single strands (35,
36). When a single-stranded end becomes too long, the kinase is
inhibited. For example, dT30 inhibits activation of the kinase by
double-stranded DNA (27). Oligo(dT) and DNA ends with unpaired single
strands are progressively less effective in activating the kinase as
the single strands increase beyond a length of 10 bases (Fig. 7, and
data not shown). In the model, kinase activity and associated
end-processing cease when an unpaired single strand penetrates deeply
into the cavity.
To complete the end-joining reaction, complementary regions of
microhomology in single strands from opposing ends are annealed to each
other, perhaps requiring a RecA-like protein. Unpaired single strands
are removed by an exonuclease or flap-endonuclease. The remaining nicks
are ligated by the XRCC4/ligase IV complex (37), leaving intact DNA
with a deletion extending to the microhomology regions. Thus, the model
explains how deletions occur in the coding joints after V(D)J
recombination. Regulation of the kinase by the processed
single-stranded ends limits the size of the deletions.
Activation of DNA-PKCS in the Absence of DNA
Ends--
Although we have demonstrated that DNA-PKCS is
activated efficiently by single-stranded DNA ends, the kinase may be
activated by other mechanisms in the absence of DNA ends. Giffen
et al. (25, 26) reported that Ku recruits
DNA-PKCS specifically to the NRE1 sequence, which is
present in the long terminal repeat of mouse mammary tumor virus and
located near the binding site for the glucocorticoid receptor. Upon
assembly at the NRE1 sequence, DNA-PK phosphorylates the glucocorticoid
receptor and represses transcription. To assess the effect of the NRE1
sequence in the context of our experimental system, we placed the NRE1
sequence in a DNA fragment ending in single-stranded loops and in a
supercoiled plasmid. In both cases, the NRE1 sequence failed to enhance
kinase activation beyond low levels in our assay, which measured
phosphorylation of a free peptide. By contrast, Giffen et
al. (25, 26) measured phosphorylation of the glucocorticoid
receptor, which was bound to a DNA sequence adjacent to the NRE1
sequence. Thus, the NRE1 sequence may recruit DNA-PK for
phosphorylation of the co-localized glucocorticoid receptor, even
though the level of kinase activity is too low for efficient
phosphorylation of free peptide.
Yavuzer et al. (38) reported that the high affinity
DNA-binding protein C1D interacts with DNA-PKCS.
Furthermore, C1D associated with supercoiled DNA can direct the
phosphorylation of free peptide by DNA-PK. Despite the absence of free
DNA ends, C1D in association with supercoiled DNA is able to activate
DNA-PK to a level comparable to that produced by linear DNA (38).
Supercoiled DNA fails to activate DNA-PKCS, but will bind
the enzyme, presumably occupying the open channel. It is possible that
the three-component interaction of supercoiled DNA, C1D, and
DNA-PKCS induces a conformational change in
DNA-PKCS that activates the kinase domain. Unpaired single
strands would activate the kinase by inducing a similar conformational
change. Perhaps a specific domain of C1D interacts with
DNA-PKCS in a way that mimics the effect of
single-stranded DNA.
In conclusion, we have discovered that DNA-PKCS is
activated by DNA via its interaction with single-stranded ends. In this case, the kinase may direct the phosphorylation of target proteins involved in DNA repair. DNA-PK might also be capable of co-localization and phosphorylation of a specific target protein, such as the glucocorticoid receptor. In this case, the effect appears to require precise juxtaposition of the target protein, because the kinase would
be only minimally activated. Finally, DNA-PK might be fully activated
in the absence of DNA ends by interacting with C1D. Interestingly, C1D
transcription is strongly induced by ionizing radiation (38). Here,
DNA-PK might phosphorylate target proteins as part of a signaling
pathway triggered by ionizing radiation.
 |
ACKNOWLEDGEMENTS |
We thank Dan Herschlag, Suzanne Admiraal,
Vaughn Smider, Pehr Harbury, and David Halpin for advice.
 |
FOOTNOTES |
*
This research was supported by gifts from Graham and Jane
Nissen and by National Institutes of Health Grant RO1 GM58120 (to G. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by the Swedish Cancer Society, STINT, Gothenburg Medical
Society, King Gustav V Jubilee Clinic Cancer Research Foundation, Swedish Society of Medicine, and Sahlgren's Hospital Research Foundation. Present address: Department of Clinical Chemistry, Sahlgren's University Hospital, Gothenberg University,
S-413 45 Gothenberg, Sweden.
§
Supported by the National Science Foundation.
¶
To whom correspondence should be addressed: M211, Dept.
of Medicine (Oncology), Stanford University Medical Center,
Stanford, CA 94305-5115. Tel.: 650-725-6442; Fax: 650-725-1420;
E-mail: chu@cmgm.stanford.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
DSB, double-strand
break;
bp, base pair(s);
DNA-PK, DNA-dependent protein
kinase;
DNA-PKCS, catalytic subunit of DNA-PK;
EMSA, electrophoretic mobility shift assay;
ssL, single-stranded loop.
 |
REFERENCES |
| 1.
|
Kharbanda, S.,
Ren, R.,
Pandey, P.,
Shafman, T.,
Feller, S.,
Weichselbaum, R.,
and Kufe, D.
(1995)
Nature
376,
785-788[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Liu, Z.-G.,
Baskaran, R.,
Lea-Chou, E. L.,
Wood, L. D.,
Chen, Y.,
Karin, M.,
and Wang, J. Y. J.
(1996)
Nature
384,
273-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Giaccia, A. J.,
and Kastan, M. B.
(1998)
Genes Dev.
12,
2973-2983[Free Full Text]
|
| 4.
|
Smider, V.,
and Chu, G.
(1997)
Semin. Immunol.
9,
189-197[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Mimori, T.,
and Hardin, J. A.
(1986)
J. Biol. Chem.
261,
10375-10379[Abstract/Free Full Text]
|
| 6.
|
Falzon, M.,
Fewell, J. W.,
and Kuff, E. L.
(1993)
J. Biol. Chem.
268,
10546-10552[Abstract/Free Full Text]
|
| 7.
|
Paillard, S.,
and Strauss, F.
(1991)
Nucleic Acids Res.
19,
5619-5624[Abstract/Free Full Text]
|
| 8.
|
de Vries, E.,
van Driel, W.,
Bergsma, W. G.,
Arnberg, A. C.,
and van der Vliet, P. C.
(1989)
J. Mol. Biol.
208,
65-78[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Blier, P.,
Griffith, A.,
Craft, J.,
and Hardin, J.
(1993)
J. Biol. Chem.
268,
7594-7601[Abstract/Free Full Text]
|
| 10.
|
Hartley, K. O.,
Gell, D.,
Smith, G. C. M.,
Zhang, H.,
Divecha, N.,
Connelly, M. A.,
Admon, A.,
Lees-Miller, S. P.,
Anderson, C. W.,
and Jackson, S. P.
(1995)
Cell
82,
849-856[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Yaneva, M.,
Kowalewski, T.,
and Lieber, M.
(1997)
EMBO J.
16,
5098-5112[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Hammarsten, O.,
and Chu, G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
525-530[Abstract/Free Full Text]
|
| 13.
|
West, R.,
Yaneva, M.,
and Lieber, M.
(1998)
Mol. Cell. Biol.
18,
5908-5920[Abstract/Free Full Text]
|
| 14.
|
Gottlieb, T. M.,
and Jackson, S. P.
(1993)
Cell
72,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Suwa, A.,
Hirakata, M.,
Takeda, Y.,
Jesch, S.,
Mimori, S.,
and Hardin, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6904-6908[Abstract/Free Full Text]
|
| 16.
|
Carter, T.,
Vancurova, I.,
Sun, I.,
Lou, W.,
and DeLeon, S.
(1990)
Mol. Cell. Biol.
10,
6460-6471[Abstract/Free Full Text]
|
| 17.
|
Blunt, T.,
Gell, D.,
Fox, M.,
Taccioli, G. E.,
Lehman, A. R.,
Jackson, S. P.,
and Jeggo, P. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10285-10290[Abstract/Free Full Text]
|
| 18.
|
Danska, J. S.,
Holland, D. P.,
Mariathasan, S.,
Williams, K. M.,
and Guidos, C. J.
(1996)
Mol. Cell. Biol.
16,
5507-5517[Abstract]
|
| 19.
|
Hendrickson, E.,
Qin, X. Q.,
Bump, E.,
Schatz, D.,
Oettinger, M.,
and Weaver, D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4061-4065[Abstract/Free Full Text]
|
| 20.
|
Fulop, G. M.,
and Phillips, R. A.
(1990)
Nature
347,
479-482[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Biedermann, K. A.,
Sun, J. R.,
Giaccia, A. J.,
Tosto, L. M.,
and Brown, J. M.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
1394-1397[Abstract/Free Full Text]
|
| 22.
|
Kurimasa, A.,
Kumano, S.,
Boubnov, N.,
Story, M.,
Tung, C. S.,
Peterson, S.,
and Chen, D.
(1999)
Mol. Cell. Biol.
19,
3877-3884[Abstract/Free Full Text]
|
| 23.
|
Baumann, P.,
and West, S. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14066-14070[Abstract/Free Full Text]
|
| 24.
|
Smider, V.,
Rathmell, W. K.,
Brown, G.,
Lewis, S.,
and Chu, G.
(1998)
Mol. Cell. Biol.
18,
6853-6858[Abstract/Free Full Text]
|
| 25.
|
Giffin, W.,
Torrance, H.,
Rodda, D.,
Prefontaine, G.,
Pope, L.,
and Hache, R.
(1996)
Nature
380,
265-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Giffin, W.,
Kwast-Welfeld, J.,
Rodda, D. J.,
Prefontaine, G. G.,
Traykova-Andonova, M.,
Zhang, Y.,
Weigel, N. L.,
Lefebvre, Y. A.,
and Hache, R. J.
(1997)
J. Biol. Chem.
272,
5647-5658[Abstract/Free Full Text]
|
| 27.
|
Leuther, K. K.,
Hammarsten, O.,
Kornberg, R. D.,
and Chu, G.
(1999)
EMBO J.
18,
1114-1123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Chan, D. W.,
and Lees-Miller, S.
(1996)
J. Biol. Chem.
271,
8936-8941[Abstract/Free Full Text]
|
| 29.
|
Morozov, V.,
Falzon, M.,
Anderson, C.,
and Kuff, E.
(1994)
J. Biol. Chem.
269,
16684-16688[Abstract/Free Full Text]
|
| 30.
|
Chiu, C.,
Cary, R.,
Chen, D.,
Peterson, S.,
and Stewart, P.
(1998)
J. Mol. Biol.
284,
1075-1081[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Darst, S. A.,
Ahlers, M.,
Meller, P. H.,
Kubalek, E. W.,
Blankenburg, R.,
Ribi, H. O.,
Ringsdorf, H.,
and Kornberg, R. D.
(1991)
Biophys. J.
59,
387-396[Abstract/Free Full Text] |